| Dana Keough, CRNA | |
|
1700 S Tamiami Trl, Sarasota, FL 34239-3509 | |
| (941) 917-9000 | |
| Not Available |
| Full Name | Dana Keough |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 1700 S Tamiami Trl, Sarasota, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033876297 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 11016721 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Smh Physician Services Inc | 1355240177 | 592 |
News Archive
Scientists are reporting that variants of a drug already approved for treating multiple sclerosis show promise as a long sought treatment for victims of bioterrorist attack with botulinum neurotoxin which is 10,000 times deadlier than cyanide and the most poisonous substance known to man.
A selection of health policy stories from Virginia, California, Colorado, Missouri, Pennsylvania, Kansas and Texas.
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
A group of proteins that act as the body's built-in line of defense against invading bacteria use a molecular trick to induce bacteria to destroy themselves, researchers at the Indiana University School of Medicine have determined. The research could point the way toward new anti-bacterial treatments that could take on bacteria that are resistant to antibiotics.
The diabetes medication metformin hydrochloride was associated with decreased weight gain in a small clinical trial of children and adolescents with autism spectrum disorder who were taking atypical antipsychotics to treat symptoms of irritability and agitation, according to an article published online by JAMA Psychiatry.
› Verified 6 days ago
| Entity Name | Smh Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346295292 PECOS PAC ID: 1355240177 Enrollment ID: O20031231000211 |
News Archive
Scientists are reporting that variants of a drug already approved for treating multiple sclerosis show promise as a long sought treatment for victims of bioterrorist attack with botulinum neurotoxin which is 10,000 times deadlier than cyanide and the most poisonous substance known to man.
A selection of health policy stories from Virginia, California, Colorado, Missouri, Pennsylvania, Kansas and Texas.
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
A group of proteins that act as the body's built-in line of defense against invading bacteria use a molecular trick to induce bacteria to destroy themselves, researchers at the Indiana University School of Medicine have determined. The research could point the way toward new anti-bacterial treatments that could take on bacteria that are resistant to antibiotics.
The diabetes medication metformin hydrochloride was associated with decreased weight gain in a small clinical trial of children and adolescents with autism spectrum disorder who were taking atypical antipsychotics to treat symptoms of irritability and agitation, according to an article published online by JAMA Psychiatry.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dana Keough, CRNA 11725 18th Pl E Unit 110, Lakewood Ranch, FL 34211-5072 Ph: () - | Dana Keough, CRNA 1700 S Tamiami Trl, Sarasota, FL 34239-3509 Ph: (941) 917-9000 |
News Archive
Scientists are reporting that variants of a drug already approved for treating multiple sclerosis show promise as a long sought treatment for victims of bioterrorist attack with botulinum neurotoxin which is 10,000 times deadlier than cyanide and the most poisonous substance known to man.
A selection of health policy stories from Virginia, California, Colorado, Missouri, Pennsylvania, Kansas and Texas.
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
A group of proteins that act as the body's built-in line of defense against invading bacteria use a molecular trick to induce bacteria to destroy themselves, researchers at the Indiana University School of Medicine have determined. The research could point the way toward new anti-bacterial treatments that could take on bacteria that are resistant to antibiotics.
The diabetes medication metformin hydrochloride was associated with decreased weight gain in a small clinical trial of children and adolescents with autism spectrum disorder who were taking atypical antipsychotics to treat symptoms of irritability and agitation, according to an article published online by JAMA Psychiatry.
› Verified 6 days ago
Mrs. Krista Marie Peverini, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3325 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-552-3480 Fax: 941-552-3485 | |
Niki Gates, RN, MSN, CRNA, APRN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1261 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-366-2360 Fax: 941-366-3123 | |
Mr. Keith Alan Ramey, BSN CRNA ARNP Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 983 S Beneva Rd, Sarasota, FL 34232 Phone: 941-954-3310 | |
Mr. Arnold Castillo Navarro, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1261 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-366-1164 Fax: 941-366-3123 | |
Liudmila Aizina, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1261 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-366-2360 | |
Beth A Beres, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1261 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-366-2360 Fax: 941-366-3123 |